Comment
. 2005;366(9483):367-8; author reply 369-70.
doi: 10.1016/S0140-6736(05)67016-X.
Effect of rimonabant on weight reduction and cardiovascular risk
- PMID: 16054931
- DOI: 10.1016/S0140-6736(05)67016-X
Item in Clipboard
Comment
Effect of rimonabant on weight reduction and cardiovascular risk
Lancet.
2005.
No abstract available
Comment in
-
Adherence to dietary advice in weight-reduction drug trials.Lancet. 2005 Nov 26;366(9500):1847-8. doi: 10.1016/S0140-6736(05)67752-5. Lancet. 2005. PMID: 16310548 No abstract available.
Comment on
-
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.Lancet. 2005 Apr 16-22;365(9468):1389-97. doi: 10.1016/S0140-6736(05)66374-X. Lancet. 2005. PMID: 15836887 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
